Pathogenic myelin-specific antibodies in multiple sclerosis target conformational proteolipid protein 1– anchored membrane domains2023

17Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.
Get full text

Abstract

B cell clonal expansion and cerebrospinal fluid (CSF) oligoclonal IgG bands are established features of the immune response in multiple sclerosis (MS). Clone-specific recombinant monoclonal IgG1 Abs (rAbs) derived from MS patient CSF plasmablasts bound to conformational proteolipid protein 1 (PLP1) membrane complexes and, when injected into mouse brain with human complement, recapitulated histologic features of MS pathology: Oligodendrocyte cell loss, complement deposition, and CD68+ phagocyte infiltration. Conformational PLP1 membrane epitopes were complex and governed by the local cholesterol and glycolipid microenvironment. Abs against conformational PLP1 membrane complexes targeted multiple surface epitopes, were enriched within the CSF compartment, and were detected in most MS patients, but not in inflammatory and noninflammatory neurologic controls. CSF PLP1 complex Abs provide a pathogenic autoantibody biomarker specific for MS.

Cite

CITATION STYLE

APA

Owens, G. P., Fellin, T. J., Matschulat, A., Salas, V., Schaller, K. L., Given, K. S., … Bennett, J. L. (2023). Pathogenic myelin-specific antibodies in multiple sclerosis target conformational proteolipid protein 1– anchored membrane domains2023. Journal of Clinical Investigation, 133(19). https://doi.org/10.1172/JCI162731

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free